Product Description: Maridebart is a human immunoglobulin G1-kappa, anti-GIPR (gastric inhibitory polypeptide receptor) monoclonal antibody[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.
CAS Number: 2761478-99-1
Molecular Weight: N/A
Research Area: Metabolic Disease
Solubility: 10 mM in DMSO
Target: GLP Receptor